Regarding the serum GLP-1 and insulin levels, the levels of GLP-1 in T2DM and T2DM + sham group were significantly lower than NC group, compared with the T2DM + sham group, GLP-1 levels increased dramatically in T2DM + RYGB and T2DM + EX-4 groups (Figure 6H)
Combining plant extracts, flavonoids, and essential micronutrients, it may help support key metabolic processes linked to appetite regulation and glucose balance
That said, FDA approval is never guaranteed and depends entirely on final clinical trial outcomes, regulatory review, manufacturing readiness, and whether the FDA determines that the benefits outweigh the risks for public use
23,24 Demand for GLP-1s has been extremely strong and is likely to increase further as new indications are expected
Phase II Clinical Data Jastreboff 2023 (NEJM) reported 24.2% bodyweight reduction at 48 weeks - the largest effect size published for any metabolic peptide in clinical trials
Some are used for diabetes, some for obesity, and some for both depending on the dose and approval